Navigation Links
Enzyme Replacement May Help in Fabry Disease
Date:12/2/2009

Whether treatment prolongs life remains unclear, researchers say

WEDNESDAY, Dec. 2 (HealthDay News) -- New research suggests that enzyme replacement therapy can make a major difference in the lives of people with Fabry disease, a rare illness that affects the kidneys, heart and brain.

The progressive disease, linked to the lack of an enzyme that helps metabolic pathways function in the body, can be fatal because it boosts the risk for a stroke, heart attack and kidney disease.

A study published Dec. 1 in The Lancet analyzed a treatment that replaced an enzyme called agalsidase alfa.

The researchers found that the treatment reduced signs of heart disease in people who had oversized hearts. It also appeared to improve kidney function, lower pain levels and improve scores on quality-of-life surveys.

"Enzyme-replacement therapy has only been available typically since 2001, and, thus, duration of exposure might be too short to assess whether this strategy prolongs life," the researchers wrote in an accompanying commentary. Whether the treatment, which they described as costly, helps people live longer needs confirmation, they noted.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on Fabry disease.



-- Randy Dotinga



SOURCE: The Lancet, news release, Dec. 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Particles Detected in Vials from Genzymes Plant Not Expected to Impact Aldurazyme or Naglazyme
2. Reportlinker Adds Boosting Immunity Through Digestion: The Relation Among Probiotics, Prebiotics and Digestive Enzymes
3. Genetic variation of enzyme linked with outcomes for women receiving tamoxifen
4. Enzyme is key to clogged arteries
5. Weight-Loss Enzyme Identified
6. LSUHSC research identifies enzyme that makes survival molecule for key vision cells
7. Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme(R) and Veretase(TM) Enzymes
8. Lung Enzyme Both Friend and Foe
9. High Activity, Plant Based Diamine Oxidase Enzyme Introduced by Bio-Research Products
10. Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines
11. Reversing effects of altered enzyme may fight brain tumor growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... Charlotte, NC (PRWEB) , ... December 08, 2016 ... ... repeal Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass ... A story movement gives people ongoing opportunities to share their unfortunate experiences; such ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Hamilton County, is embarking on a charity drive ... specializes in finding new homes for orphaned or neglected senior dogs in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an ... families in and around the Cape Coral area, is embarking on a charity drive ... of Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida works to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Bill ... and business owners in and around central Kansas, is joining the Youth Horizons ... in the region. , Headquartered in Wichita, Youth Horizons works to empower area ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced today ... Equality Index (CEI). This is the ninth time that ... designated as a Best Place to Work for LGBT ... CEI is a national benchmarking report on corporate policies ... bisexual and transgender (LGBT) employees. "We ...
(Date:12/8/2016)... India , December 8, 2016 ... report "Sugar-Based Excipients Market by Product (Actual Sugars, ... Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, ... by MarketsandMarkets, the market has witnessed healthy growth ... grow at a CAGR of 4.3% between 2016 ...
(Date:12/8/2016)... According to a new market research report "Wearable ... (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution ... market, in terms of value, is projected to reach 12.14 Billion by ... during the forecast period. Continue Reading ... ...
Breaking Medicine Technology: